Bayer launches jumbo rights issue as Monsanto deal closes

Bayer, the German life sciences company, this week unveiled the terms for a €6bn rights issue, after its acquisition of Monsanto, the US agrochemical and biotech company, cleared its final regulatory hurdles last week.

  • By Aidan Gregory
  • 04 Jun 2018

In a statement on Monday, Bayer said that it expected to close the takeover on Thursday, after the deal received conditional approval from the Department of Justice in the US on Tuesday last week.

Bank of America Merrill Lynch and Credit Suisse, the global co-ordinators, signed an underwriting agreement ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 161,597.45 701 8.06%
2 Citi 158,100.45 638 7.89%
3 Bank of America Merrill Lynch 131,322.73 520 6.55%
4 Barclays 126,396.71 489 6.30%
5 HSBC 104,257.54 522 5.20%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 12,900.23 34 6.65%
2 BNP Paribas 12,334.48 61 6.36%
3 UniCredit 11,196.47 58 5.77%
4 Citi 9,580.75 37 4.94%
5 Deutsche Bank 8,953.95 35 4.62%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Morgan Stanley 5,454.13 25 10.64%
2 JPMorgan 4,766.13 27 9.30%
3 Goldman Sachs 4,280.20 20 8.35%
4 Citi 3,649.88 23 7.12%
5 UBS 3,602.23 16 7.03%